Skip to main content

Table 2 Adverse events by treatment

From: Randomized phase III trial of radiotherapy or chemoradiotherapy with topotecan and cisplatin in intermediate-risk cervical cancer patients after radical hysterectomy

Adverse event

RT

CCRT

CCRT + CT

P value

(Grade),N = 13

(Grade),N = 15

(Grade),N = 5

3

4

3

4

3

4

Neutropenia

2

0

2

5

3

2

0.002

Anemia

1

0

2

0

1

0

0.128

Thrombocytopenia

1

0

3

1

1

1

0.079

Nausea/vomiting

1

0

2

0

1

0

0.446

Diarrhea

1

0

2

1

1

0

0.383

Genitourinary

1

0

1

0

1

0

0.673

Neurotoxicity

0

0

0

0

0

0

1

Renal

0

0

0

0

0

0

1

Hepatic

0

0

1

0

1

0

0.339

  1. Abbreviations:RT radiotherapy, CCRT chemoradiotherapy, CCRT + CT chemoradiotherapy plus consolidation chemotherapy.